Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-24-032390
Filing Date
2024-10-29
Accepted
2024-10-29 09:24:17
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 pbla20241029o_424b3.htm 424B3 40320
2 EXHIBIT 10.1 ex_739274.htm EX-10.1 55415
3 EXHIBIT 10.2 ex_739275.htm EX-10.2 148038
4 EXHIBIT 10.3 ex_739276.htm EX-10.3 46636
5 logo01.jpg GRAPHIC 8243
  Complete submission text file 0001437749-24-032390.txt   303152
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271729 | Film No.: 241402872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)